Philadelphia Trust Company’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-20,107
Closed -$2.22M 222
2016
Q4
$2.22M Buy
20,107
+14,409
+253% +$1.6M 0.18% 92
2016
Q3
$673K Sell
5,698
-6,682
-54% -$787K 0.06% 133
2016
Q2
$1.39M Buy
+12,380
New +$1.33M 0.12% 102
2015
Q1
Sell
-15,248
Closed -$1.41M 175
2014
Q4
$1.41M Buy
+15,248
New +$1.35M 0.11% 86
2014
Q2
Sell
-7,263
Closed -$613K 177
2014
Q1
$613K Sell
7,263
-13,980
-66% -$1.11M 0.04% 125
2013
Q4
$1.67M Sell
21,243
-35,552
-63% -$3.03M 0.11% 84
2013
Q3
$4.84M Sell
56,795
-217,807
-79% -$18.3M 0.33% 55
2013
Q2
$23.6M Buy
+274,602
New +$22.8M 1.77% 32

Other funds holding LH

Philadelphia Trust Company's LH Position: Q1 2017 in Review

Philadelphia Trust Company sold out of Labcorp (LH) in Q1 2017, closing a stake of 20,107 shares — an estimated $2.22M sold.

Philadelphia Trust Company first reported a position in LH in Q2 2013 and held it in 8 quarters. The position peaked at $23.6M in Q2 2013. 693 funds tracked by Wall St. Rank hold LH as of Q1 2017.

  • Philadelphia Trust Company reported no remaining Labcorp position as of Q1 2017 after selling out during the quarter.
  • Philadelphia Trust Company sold 20,107 Labcorp shares in Q1 2017, an estimated $2.22M.
  • Philadelphia Trust Company first reported a position in Labcorp in Q2 2013 and held it in 8 quarters.
  • Philadelphia Trust Company's Labcorp position peaked at $23.6M in Q2 2013.
  • 693 funds tracked by Wall St. Rank held Labcorp as of Q1 2017.

Based on Philadelphia Trust Company's 13F filing for Q1 2017, filed 15 May 2017.